L. Rothenburg

A Meta-Analysis of Cytokines in Alzheimer's Disease

N. Herrmann, W. Swardfager, K. Lanctôt, 2010, Biological Psychiatry.

Perceptions of Natural Health Products Among Patients Attending a Memory Clinic

P. Rochon, N. Herrmann, K. Lanctôt, 2006, American journal of Alzheimer's disease and other dementias.

A SPECT Study of Apathy in Alzheimer’s Disease

Sandra E Black, Nathan Herrmann, N. Herrmann, 2007, Dementia and Geriatric Cognitive Disorders.

Methylphenidate for the Treatment of Apathy in Alzheimer Disease: Prediction of Response Using Dextroamphetamine Challenge

Sandra E Black, Nathan Herrmann, N. Herrmann, 2008, Journal of clinical psychopharmacology.

A functional neuroimaging study of appetite loss in Alzheimer’s disease

N. Herrmann, K. Lanctôt, L. Rothenburg, 2008, Journal of the Neurological Sciences.

A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease

N. Herrmann, K. Lanctôt, L. Rothenburg, 2006, Dementia and Geriatric Cognitive Disorders.

The Relationship Between Inflammatory Markers and Post Stroke Cognitive Impairment

A. Kiss, D. Gladstone, N. Herrmann, 2010, Journal of geriatric psychiatry and neurology.

Behavioral correlates of GABAergic disruption in Alzheimer's disease

N. Herrmann, K. Lanctôt, L. Rothenburg, 2006, International Psychogeriatrics.

Apathy associated with Alzheimer disease: use of dextroamphetamine challenge.

N. Herrmann, K. Lanctôt, L. Rothenburg, 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Commentary: Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels

N. Herrmann, K. Lanctôt, L. Rothenburg, 2008, Experimental Neurology.

A SPECT Study of Sleep Disturbance and Alzheimer’s Disease

N. Lobaugh, N. Herrmann, K. Lanctôt, 2009, Dementia and Geriatric Cognitive Disorders.